Skip to content
10-K

Annual Report

WEIKANG BIO-TECHNOLOGY GROUP CO., INC.

0001144204-12-018721

← back to feed
Filed
Mar 30, 2012 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Mar 29, 2012 34.45M sh
Shares Diluted FY 2011 · Dec 31, 2011 32.92M sh
Shares Diluted FY 2011 · Dec 31, 2010 28.09M sh
Capex FY 2011 · Dec 31, 2011 $14.88M
Capex FY 2011 · Dec 31, 2010 $59.3K
Operating Cash Flow FY 2011 · Dec 31, 2011 $30.45M
Operating Cash Flow FY 2011 · Dec 31, 2010 $34.19M
Cash And Equivalents FY 2011 · Dec 31, 2011 $70.78M
Cash And Equivalents FY 2011 · Dec 31, 2010 $50.36M
Cash And Equivalents FY 2011 · Dec 31, 2009 $11.38M
Stockholders Equity FY 2011 · Dec 31, 2011 $112.1M
Stockholders Equity FY 2011 · Dec 31, 2010 $66.93M
Stockholders Equity FY 2011 · Dec 31, 2009 $23.42M
Current Liabilities FY 2011 · Dec 31, 2011 $7.56M
Current Liabilities FY 2011 · Dec 31, 2010 $8.21M
Total Liabilities FY 2011 · Dec 31, 2011 $11.09M
Total Liabilities FY 2011 · Dec 31, 2010 $11.68M
Current Assets FY 2011 · Dec 31, 2011 $81.85M
Current Assets FY 2011 · Dec 31, 2010 $52.55M
Total Assets FY 2011 · Dec 31, 2011 $123.19M
Total Assets FY 2011 · Dec 31, 2010 $78.61M
Eps Diluted FY 2011 · Dec 31, 2011 $0.90
Eps Diluted FY 2011 · Dec 31, 2010 $0.87
Eps Basic FY 2011 · Dec 31, 2011 $0.90
Eps Basic FY 2011 · Dec 31, 2010 $0.87
Sga Expense FY 2011 · Dec 31, 2011 $12.54M
Sga Expense FY 2011 · Dec 31, 2010 $5.45M
Rd Expense FY 2011 · Dec 31, 2011 $22.1K
Rd Expense FY 2011 · Dec 31, 2010 $2.54M
Net Income FY 2011 · Dec 31, 2011 $29.63M
Net Income FY 2011 · Dec 31, 2010 $24.44M
Operating Income FY 2011 · Dec 31, 2011 $42.3M
Operating Income FY 2011 · Dec 31, 2010 $33.68M
Gross Profit FY 2011 · Dec 31, 2011 $59.59M
Gross Profit FY 2011 · Dec 31, 2010 $45.02M
Cost Of Revenue FY 2011 · Dec 31, 2011 $42.09M
Cost Of Revenue FY 2011 · Dec 31, 2010 $29.54M
Revenue FY 2011 · Dec 31, 2011 $101.68M
Revenue FY 2011 · Dec 31, 2010 $74.55M